TDD Industry News and Views: Weekly Updates on Comings, Goings, and Other Happenings in Dermatology
Rion Aesthetics Rolls Out Refillable Packaging for Exosome Serums Rion Aesthetics’ refillable packaging is made from 50% post-consumer recycled (PCR) plastic with most elements 100% ready for recycling. “The redesigned bottles embody simplicity and functionality, aiming to add consumer-friendly innovation while minimizing the environmental footprint traditionally associated with skincare purchases,” says Alisa Lask, the CEO of Rion […]
COVID-19 Infection May Up Alopecia Risk
COVID-19 has been linked to new onsets or flares of systemic lupus erythematosus, inflammatory bowel disease, and rheumatoid arthritis, and a new nationwide study out of South Korea suggests it may also increase risk for onset, exacerbation, and recurrence of alopecia areata (AA). The researchers conducted a population-based cohort study to investigate the association between […]
Addressing These Five Factors Will Empower Your HS Patients to Seek Treatment
With the recent U.S. Food and Drug Administration approval of secukinumab (Cosentyx, Novartis) and a full pipeline, hidradenitis suppurativa (HS) is having a moment. Up until now, the TNF blocker adalimumab was the only approved treatment for moderate to severe HS in people 12 years and older. Now that there are more HS treatment options, Nicole Salame, MD, and […]
VYN201 Produces Positive Biomarker Changes in Vitiligo
VYN201 demonstrated a positive effect on key biomarkers relevant to nonsegmental vitiligo, according to new data from a Phase 1b Trial. VYNE Therapeutics Inc.’s VYN201 is a pan-bromodomain BET inhibitor designed to be locally administered to address diseases involving multiple, diverse inflammatory cell signaling pathways while providing low systemic exposure. BET inhibitors have the potential to […]